Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries

Research output: Contribution to journal › Letter › Research › peer-review

  • Stylianos Georgiadis
  • Anne Gitte Loft
  • Asta Linauskas
  • Hanne Lindegaard
  • Oliver Hendricks
  • Dorte V. Jensen
  • Birgitte Lange Andersen
  • Kamilla Danebod
  • Anders Villumsen
  • Grith Eng
  • Charlotte Wiell
  • Natalia Manilo
  • Salome Kristensen
  • Johnny Raun
  • Jolanta Grydehøj
  • Stavros Chrysidis
  • Mette Nørgaard
  • Frank Mehnert
  • Niels Steen Krogh
Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume79
Issue number6
Pages (from-to)846-848
ISSN0003-4967
DOIs
Publication statusPublished - May 2020

    Research areas

  • Anti-TNF, DMARDs (biologic), epidemiology, rheumatoid arthritis

ID: 244322755